Pfizer has notified the FDA that there may be an impending shortage of penicillin, citing an increase in syphilis infections and other shortages.
In a letter posted to the FDA’s website and dated Monday, the pharma said there is “limited supply” and an “impending stock out situation” for prefilled Bicillin L-A and Bicillin C-R syringes, which are also used to treat pneumonia, strep throat and other bacterial infections. To alleviate the possible shortage, Pfizer said it’s prioritizing the production of Bicillin L-A prefilled syringes, according to a Pfizer spokesperson.
The company is warning that all Bicillin C-R products are likely to be depleted in the third quarter of this year, and some forms of the medication may be unavailable until the second or third quarter of next year. Pfizer also said it expects to run out of pediatric Bicillin L-A sometime this month.
According to Erin…
Click here to view original post
